17 April, 2018
FiTalent (FIT-II) invests in ONCOSTELLAE, a biotech startup company developing small-molecule drugs with innovative scaffolds (NCEs) that modulate clinically validated therapeutic targets in oncology and inflammatory/autoimmune diseases
FiTalent (FIT-II) continues with its investment activity adding PLAYSTARK to its investment portfolio. Through the Venture Capital line, FiTalent invests in this company whose goal is the development of eSports video games.
28 September, 2017
SOUTH SUMMIT is the leading international investor event, which contacts the most innovative entrepreneur’s with the most important international investors, and the companies interested in improving their competitiveness through innovation. SOUTH SUMMIT will be held in Madrid the next 4-6 October.
1 September, 2017
FiTalent begins its activity
FiTalent begins its activity in search of new investment opportunities, being present in the most important Investment Forums at national level (KEIRETSU, ASEBIO, IESE, ESADE ...)